Gradient Investments LLC Has $66,000 Stake in Xylem Inc. (NYSE:XYL)

Gradient Investments LLC boosted its position in shares of Xylem Inc. (NYSE:XYL) by 28.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 576 shares of the industrial products company’s stock after acquiring an additional 128 shares during the period. Gradient Investments LLC’s holdings in Xylem were worth $66,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of XYL. First Trust Advisors LP raised its position in shares of Xylem by 399.3% during the first quarter. First Trust Advisors LP now owns 2,951,349 shares of the industrial products company’s stock valued at $251,632,000 after buying an additional 2,360,214 shares during the last quarter. Morgan Stanley raised its position in shares of Xylem by 145.5% during the fourth quarter. Morgan Stanley now owns 3,731,215 shares of the industrial products company’s stock valued at $412,561,000 after buying an additional 2,211,083 shares during the last quarter. State Street Corp raised its position in shares of Xylem by 28.3% during the second quarter. State Street Corp now owns 9,868,835 shares of the industrial products company’s stock valued at $1,111,428,000 after buying an additional 2,176,790 shares during the last quarter. Norges Bank acquired a new position in shares of Xylem during the fourth quarter valued at about $197,762,000. Finally, Vanguard Group Inc. raised its position in shares of Xylem by 7.6% during the first quarter. Vanguard Group Inc. now owns 20,390,911 shares of the industrial products company’s stock valued at $1,738,529,000 after buying an additional 1,435,798 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Price Performance

Shares of Xylem stock opened at $129.24 on Monday. The company has a current ratio of 1.76, a quick ratio of 1.30 and a debt-to-equity ratio of 0.22. The stock has a market capitalization of $31.25 billion, a price-to-earnings ratio of 47.51, a P/E/G ratio of 2.62 and a beta of 1.10. Xylem Inc. has a 1-year low of $87.59 and a 1-year high of $130.86. The firm’s 50-day moving average price is $123.39 and its two-hundred day moving average price is $108.90.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.03. Xylem had a net margin of 8.27% and a return on equity of 9.65%. The firm had revenue of $2.12 billion for the quarter, compared to analysts’ expectations of $2.05 billion. During the same period in the prior year, the firm earned $0.92 earnings per share. The company’s quarterly revenue was up 40.6% compared to the same quarter last year. On average, equities analysts predict that Xylem Inc. will post 4.13 earnings per share for the current fiscal year.

Xylem Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 20th. Stockholders of record on Wednesday, February 21st were paid a dividend of $0.36 per share. This is a boost from Xylem’s previous quarterly dividend of $0.33. This represents a $1.44 annualized dividend and a dividend yield of 1.11%. The ex-dividend date was Tuesday, February 20th. Xylem’s dividend payout ratio is 52.94%.

Analyst Upgrades and Downgrades

XYL has been the subject of a number of research analyst reports. Raymond James raised shares of Xylem from an “underperform” rating to a “market perform” rating in a research report on Thursday, January 4th. Royal Bank of Canada upped their price objective on shares of Xylem from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Wednesday, February 7th. Wolfe Research initiated coverage on shares of Xylem in a research note on Wednesday, December 13th. They issued an “outperform” rating and a $127.00 target price on the stock. Citigroup upped their target price on shares of Xylem from $122.00 to $126.00 and gave the company a “neutral” rating in a research note on Wednesday, February 7th. Finally, BNP Paribas initiated coverage on shares of Xylem in a research note on Tuesday, March 12th. They issued an “outperform” rating and a $150.00 target price on the stock. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $134.00.

Insider Activity

In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total transaction of $122,890.00. Following the sale, the chief accounting officer now directly owns 2,935 shares of the company’s stock, valued at $360,682.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total value of $122,890.00. Following the transaction, the chief accounting officer now directly owns 2,935 shares in the company, valued at $360,682.15. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the transaction, the senior vice president now owns 11,750 shares in the company, valued at $1,431,032.50. The disclosure for this sale can be found here. 0.90% of the stock is owned by insiders.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.